Company / Shareholders' Equity
Pediatrix Medical Group Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$865.9M
FY2025
5-year range
$764.9M / $896.7M
FY2021-FY2025
Trend
+13.2%
vs FY2024
Sector context
#89 of 161
Health Care
What the data says
At $866M, Pediatrix Medical Group's shareholders' equity ranks #89 of 161 in the Health Care sector. Shareholders' Equity returned to growth in FY2025 after 3 years of decline, reaching $866M.
Based on SEC 10-K filings.
$866M in FY2025 with a 5-year CAGR of +3.0%.
Remained stable around $866M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- +3.0%
- 10-Year CAGR
- -
Sector benchmark
#89 of 161 in Health CareTop 55% of 161This company $865.9M Sector average $5.1B
▼
-82.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.0%, indicating consistent growth.
- In FY2025, shareholders' equity increased 13.2% year-over-year.
- Ranks #89 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.65 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $865.9M | +13.2% |
| FY2024 | $764.9M | -9.9% |
| FY2023 | $849.1M | -4.8% |
| FY2022 | $891.6M | -0.6% |
| FY2021 | $896.7M | +19.9% |
| FY2020 | $747.7M | -50.1% |
| FY2019 | $1.5B | -51.5% |
| FY2018 | $3.1B | +0.7% |
| FY2017 | $3.1B | +11.1% |
| FY2016 | $2.8B | +13.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026